The treatment of EphrinB2-Fc on A549 cells increased the ratio of CD133+ cancer stem cells and knockdown of Sox2 and Nanog by siRNA could reverse the enrichment of cancer stem cells induced by EphB1 trans signaling (Fig. 8C, D). The gene discussed is EFNB2; the disease is cancer.